Medifast Announces Chief Legal Officer Resignation and Transition
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
The latest announcement is out from Medifast ( (MED) ).
On May 29, 2026, Medifast, Inc.’s Chief Legal Officer and Corporate Secretary, Jason L. Groves, Esq., resigned from the company, and on May 31, 2026, he entered into a separation and release agreement that provides him with a one-time cash severance equal to one month of his annual base salary, subject to standard tax withholdings and compliance conditions. Medifast stated that Groves’ departure did not stem from any disagreement or operational issues and has begun searching for a permanent replacement, signaling an orderly leadership transition in its legal function rather than a shift in strategic direction.
The most recent analyst rating on (MED) stock is a Hold
with a $12.00 price target.
To see the full list of analyst forecasts on Medifast stock,
see the MED Stock Forecast page.
Spark’s Take on MED Stock
According to Spark, TipRanks’ AI Analyst, MED is a Neutral.
The score is held down primarily by weak financial performance (revenue declines, ongoing losses, and negative TTM free cash flow), partially offset by a strong balance sheet and improving technical trend. Earnings-call commentary adds modest support via signs of stabilization and cost-savings plans, but guidance still implies continued near-term losses and execution risk.
To see Spark’s full report on MED stock,
click here.
More about Medifast
Medifast, Inc. is a U.S.-based health and wellness company best known for its OPTAVIA-branded weight-management and nutrition programs, which combine meal replacements with coaching and lifestyle support to target consumers seeking structured, science-based approaches to weight loss and long-term health.
Average Trading Volume: 235,602
Technical Sentiment Signal: Sell
Current Market Cap: $139.3M
See more insights into MED stock on TipRanks’ Stock Analysis page.
